Overview
Atropos Health turns vast clinical and medical datasets into publication-grade real-world evidence in minutes. Originating from Stanford's 'Green Button' project, the company lets clinicians, health systems and life-science organizations ask specific medical questions and receive rigorous, observational evidence to inform care decisions where randomized trials do not exist. Its platform includes the GENEVA OS analytics engine and ChatRWD, a conversational interface for generating evidence.
Funding and Network
Founded in 2019 by Brigham Hyde, Saurabh Gombar and Nigam Shah, Atropos Health has raised roughly $54 million, including a $33 million Series B in 2024 led by Valtruis with participation from Cencora, McKesson Ventures and Merck Global Health Innovation Fund. The company operates the Atropos Evidence Network spanning hundreds of millions of patient records.
Why It Matters
Most clinical questions lack direct trial evidence, leaving decisions to intuition. By rapidly producing transparent, real-world studies, Atropos Health brings data-driven rigor to everyday medical decisions and accelerates evidence generation for pharma and providers.